Syndax Pharmaceuticals (SNDX) Payables: 2015-2025
Historic Payables for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Sep 2025 value amounting to $13.8 million.
- Syndax Pharmaceuticals' Payables rose 182.28% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.9 million, marking a year-over-year increase of 49.99%. This contributed to the annual value of $11.6 million for FY2024, which is 16.72% up from last year.
- Latest data reveals that Syndax Pharmaceuticals reported Payables of $13.8 million as of Q3 2025, which was down 20.33% from $17.4 million recorded in Q2 2025.
- Syndax Pharmaceuticals' Payables' 5-year high stood at $17.4 million during Q2 2025, with a 5-year trough of $3.6 million in Q2 2021.
- In the last 3 years, Syndax Pharmaceuticals' Payables had a median value of $10.0 million in 2025 and averaged $10.3 million.
- In the last 5 years, Syndax Pharmaceuticals' Payables decreased by 27.44% in 2021 and then surged by 182.28% in 2025.
- Quarterly analysis of 5 years shows Syndax Pharmaceuticals' Payables stood at $5.7 million in 2021, then dropped by 23.27% to $4.3 million in 2022, then skyrocketed by 128.99% to $10.0 million in 2023, then climbed by 16.72% to $11.6 million in 2024, then soared by 182.28% to $13.8 million in 2025.
- Its Payables stands at $13.8 million for Q3 2025, versus $17.4 million for Q2 2025 and $10.0 million for Q1 2025.